TAKEDA PHARMACEUTIC-SP ADR (TAK) Institutional Shareholders
TAKEDA PHARMACEUTIC-SP ADR (TAK) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.66B in TAK holdings during the latest filing period.
Capital Research Global Investors is currently the largest disclosed institutional shareholder of TAK tracked by InsiderSet, reporting ownership valued at approximately $309.34M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $367.62M, representing an estimated gain of +18.84% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 62% of the total disclosed TAK value among the investors covered in this analysis. Major shareholders include Capital Research Global Investors, Fmr Llc, Morgan Stanley, and several other long-term asset managers with concentrated positions in TAKEDA PHARMACEUTIC-SP ADR (TAK).
This page ranks the largest institutional TAK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
372
Total Reported Value
$1.66B
Largest Holder
Capital Research Global Investors
Largest Position
$309.34M
Insider Transactions (90d)
44
Latest Filing Quarter
Q2 2026
New Institutional Positions
56
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 0.04% | 19,297,680 | $309,341,810 | $367,620,804 | +$58,278,994 | +18.84% | |
| Fmr Llc | 0.01% | 9,599,302 | $153,876,803 | $182,866,703 | +$28,989,900 | +18.84% | |
| Morgan Stanley | 0.01% | 6,994,924 | $112,128,655 | $133,253,302 | +$21,124,647 | +18.84% | |
| Adage Capital Partners Gp, L.L.C. | 0.14% | 6,050,771 | $96,993,859 | $115,267,188 | +$18,273,329 | +18.84% | |
| Goldman Sachs Group Inc | 0.01% | 5,125,032 | $82,154,258 | $97,631,860 | +$15,477,602 | +18.84% | |
| Brandes Investment Partners, Lp | 0.51% | 4,539,347 | $72,765,928 | $86,474,560 | +$13,708,632 | +18.84% | |
| Arrowstreet Capital, Limited Partnership | 0.03% | 3,732,924 | $59,838,772 | $71,112,202 | +$11,273,430 | +18.84% | |
| Blackrock, Inc. | 0.00% | 3,688,166 | $59,121,313 | $70,259,562 | +$11,138,249 | +18.84% | |
| Renaissance Technologies LLC | Jim Simons | 0.06% | 2,568,000 | $41,165,040 | $48,920,400 | +$7,755,360 | +18.84% |
| Qube Research & Technologies Ltd | 0.04% | 2,207,432 | $35,385,135 | $42,051,580 | +$6,666,445 | +18.84% | |
| First Trust Advisors Lp | 0.02% | 2,114,912 | $33,902,011 | $40,289,074 | +$6,387,063 | +18.84% | |
| D. E. Shaw & Co., Inc. | 0.02% | 2,049,467 | $32,852,956 | $39,042,346 | +$6,189,390 | +18.84% | |
| Managed Asset Portfolios, Llc | 3.34% | 1,823,884 | $29,236,866 | $34,744,990 | +$5,508,124 | +18.84% | |
| Northern Trust Corp | 0.00% | 1,740,313 | $27,897,218 | $33,152,963 | +$5,255,745 | +18.84% | |
| Van Eck Associates Corp | 0.02% | 1,674,005 | $26,834,300 | $31,889,795 | +$5,055,495 | +18.84% | |
| Envestnet Asset Management Inc | 0.01% | 1,598,174 | $25,617,763 | $30,445,215 | +$4,827,452 | +18.84% | |
| Aqr Capital Management Llc | 0.01% | 1,525,686 | $24,456,751 | $29,064,318 | +$4,607,567 | +18.84% | |
| Quantinno Capital Management Lp | 0.03% | 1,402,650 | $22,484,494 | $26,720,483 | +$4,235,989 | +18.84% | |
| Wells Fargo & Company/Mn | 0.00% | 1,150,820 | $18,447,659 | $21,923,121 | +$3,475,462 | +18.84% | |
| Millennium Management Llc | 0.01% | 1,050,698 | $16,842,689 | $20,015,797 | +$3,173,108 | +18.84% | |
| Ubs Group Ag | 0.00% | 911,319 | $14,608,444 | $17,360,627 | +$2,752,183 | +18.84% | |
| Crossmark Global Holdings, Inc. | 0.16% | 783,835 | $12,564,875 | $14,932,057 | +$2,367,182 | +18.84% | |
| Jpmorgan Chase & Co | 0.00% | 744,916 | $11,903,771 | $14,190,650 | +$2,286,879 | +19.21% | |
| Stifel Financial Corp | 0.01% | 722,863 | $11,587,485 | $13,770,540 | +$2,183,055 | +18.84% | |
| Bnp Paribas Financial Markets | 0.01% | 714,143 | $11,447,712 | $13,604,424 | +$2,156,712 | +18.84% | |
| Royal Bank Of Canada | 0.00% | 692,900 | $11,107,000 | $13,199,745 | +$2,092,745 | +18.84% | |
| Focus Partners Wealth | 0.01% | 679,950 | $10,901,024 | $12,953,048 | +$2,052,024 | +18.82% | |
| Charles Schwab Investment Management Inc | 0.00% | 619,021 | $9,922,907 | $11,792,350 | +$1,869,443 | +18.84% | |
| American Century Companies Inc | 0.00% | 584,560 | $9,370,497 | $11,135,868 | +$1,765,371 | +18.84% | |
| Lpl Financial Llc | 0.00% | 555,228 | $8,900,303 | $10,577,093 | +$1,676,790 | +18.84% | |
| Balyasny Asset Management L.P. | 0.01% | 511,336 | $8,196,716 | $9,740,951 | +$1,544,235 | +18.84% | |
| Two Sigma Investments, Lp | 0.01% | 485,733 | $7,786,300 | $9,253,214 | +$1,466,914 | +18.84% | |
| Us Bancorp \De\ | 0.01% | 466,714 | $7,481,425 | $8,890,902 | +$1,409,477 | +18.84% | |
| Pfm Health Sciences, Lp | 0.62% | 444,173 | $7,120,093 | $8,461,496 | +$1,341,403 | +18.84% | |
| Bleakley Financial Group, Llc | 0.09% | 432,956 | $6,940,285 | $8,247,812 | +$1,307,527 | +18.84% | |
| Raymond James Financial Inc | 0.00% | 408,739 | $6,552,092 | $7,786,478 | +$1,234,386 | +18.84% | |
| Citigroup Inc | 0.00% | 396,457 | $6,355,206 | $7,552,506 | +$1,197,300 | +18.84% | |
| Federated Hermes, Inc. | 0.01% | 376,858 | $6,041,034 | $7,179,145 | +$1,138,111 | +18.84% | |
| Qrg Capital Management, Inc. | 0.05% | 372,752 | $5,975,215 | $7,100,926 | +$1,125,711 | +18.84% | |
| Ethic Inc. | 0.07% | 365,253 | $5,854,998 | $6,958,070 | +$1,103,072 | +18.84% | |
| Vestmark Advisory Solutions, Inc. | 0.05% | 351,770 | $5,638,878 | $6,701,219 | +$1,062,341 | +18.84% | |
| Assetmark, Inc | 0.01% | 314,687 | $5,044,432 | $5,994,787 | +$950,355 | +18.84% | |
| Mariner, Llc | 0.01% | 308,157 | $4,939,586 | $5,870,391 | +$930,805 | +18.84% | |
| Bank Of America Corp | 0.00% | 307,312 | $4,926,218 | $5,854,294 | +$928,076 | +18.84% | |
| Pathstone Holdings, Llc | 0.02% | 241,293 | $4,468,746 | $4,596,632 | +$127,886 | +2.86% | |
| Hrt Financial Lp | 0.01% | 278,706 | $4,467,000 | $5,309,349 | +$842,349 | +18.86% | |
| Hudson Bay Capital Management Lp | 0.02% | 275,000 | $4,408,250 | $5,238,750 | +$830,500 | +18.84% | |
| Hantz Financial Services, Inc. | 0.06% | 269,650 | $4,322,000 | $5,136,833 | +$814,833 | +18.85% | |
| Natixis Advisors, Llc | 0.00% | 268,328 | $4,301,000 | $5,111,648 | +$810,648 | +18.85% | |
| Clean Yield Group | 0.91% | 227,988 | $3,654,648 | $4,343,171 | +$688,523 | +18.84% |
Frequently asked questions about TAK
Who owns the most TAK stock?
The largest holders of TAK are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TAKEDA PHARMACEUTIC-SP ADR (TAK).
Is TAK widely held by superinvestors?
Many widely followed stocks like TAK appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TAK is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.